Home > PE Ratio > KWALITY PHARMACEUTICALS

KWALITY PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of KWALITY PHARMACEUTICALS is 24.70.

Share Price ₹702.0Feb 11,2025
Market Cap ₹730.1 Cr
Earnings-TTM₹29.6 CrTTM-Consolidated Results
Price/Earnings24.70xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for KWALITY PHARMACEUTICALS
Please provide your vote to see the results
KWALITY PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PE (Price/Earnings) ratio of KWALITY PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of KWALITY PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹730.1 Cr] as on Feb 11,2025

(/) Earnings [ ₹29.6 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 24.70x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for KWALITY PHARMACEUTICALS , the investors are currently willing to pay 24.70 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of KWALITY PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of KWALITY PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of KWALITY PHARMACEUTICALS


PE Ratio Performance Analysis for KWALITY PHARMACEUTICALS

- KWALITY PHARMACEUTICALS 's latest p/e ratio is 24.70x.

- KWALITY PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 9.27x.

- KWALITY PHARMACEUTICALS 's operated at median p/e ratio of 5.02x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, KWALITY PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 17.85x.

- KWALITY PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 3.19x.


How does KWALITY PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
KWALITY PHARMACEUTICALS 29.5624.70730.1
SUN PHARMACEUTICAL INDUSTRIES LTD11,486.0035.51407,827.0
CIPLA LTD5,000.4323.46117,322.0
DR REDDYS LABORATORIES LTD5,428.6018.63101,116.0
ZYDUS LIFESCIENCES LTD4,591.8020.6494,752.0
DIVIS LABORATORIES LTD2,067.0076.41157,931.0
MANKIND PHARMA LTD2,050.7349.32101,137.0
TORRENT PHARMACEUTICALS LTD1,862.0056.44105,086.0
LUPIN LTD2,651.9435.5794,327.2
AUROBINDO PHARMA LTD3,500.2519.0366,606.3
ABBOTT INDIA LTD1,334.4646.4061,914.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs KWALITY PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.63x
Max industry PE 76.41x
Median industry PE 35.51x
Average industry PE 36.92x



You may also like the below Video Courses